Navigation Links
Dow AgroSciences, China National Rice Research Institute Announce Collaboration on Rice Research
Date:2/17/2009

INDIANAPOLIS and HANGZHOU, China, Feb. 17 /PRNewswire-FirstCall/ -- Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company (NYSE: DOW), and the China National Rice Research Institute (CNRRI) of Hangzhou, China, announced today that they have entered into a research agreement to combine the strengths of Dow AgroSciences' platform of traits and technologies with CNRRI's leading rice germplasm.

"We look forward to working with CNRRI to introduce novel technologies in rice in China and the rest of the world to improve the productivity of one of the world's most important food crops and to help address the needs of our growing global population," said Daniel R. Kittle, Ph.D., vice president, R&D, Dow AgroSciences and Core Biotechnology for The Dow Chemical Company.

"We are confident that with Dow AgroSciences, a global leader in biotechnology, we will bring cutting edge technologies and innovative solutions to agriculture through this collaboration project," said Director General Cheng Shihua, Ph.D., China National Rice Research Institute.

About China National Rice Research Institute (CNRRI)

China National Rice Research Institute (CNRRI) is an integrative research institute of basic rice science in China. It was established in Hangzhou, Zhejiang Province as approved by the Chinese State Council in June 1981, under the dual leadership of Chinese Academy of Agricultural Sciences (CAAS) and the Zhejiang Provincial Government.

CNRRI focuses on basic and applicable researches with priority on solving significant scientific and technical problems in rice production. Engaging in rice research at population, individual, tissue, cell, and molecular levels, its mission is to contribute food security, nutrition improvement and environment protection.

About Dow AgroSciences

Dow AgroSciences LLC, based in Indianapolis, Indiana, USA, is a top-tier agricultural company that combines the power of science and technology with the "Human Element" to constantly improve what is essential to human progress. Dow AgroSciences provides innovative technologies for crop protection, pest and vegetation management, seeds, traits, and agricultural biotechnology to serve the world's growing population. Global sales for Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical Company, were $4.5 billion in 2008. Learn more at www.dowagro.com


'/>"/>
SOURCE Dow AgroSciences LLC
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration
2. Dow AgroSciences, Martek Biosciences Form Alliance to Bring Omega-3 Fatty Acids to Food Industry
3. Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestone in Plant Agriculture Collaboration
4. China Biologic Products High-Purity Human Albumin Research and Development Project to be Listed in the National Torch Plan
5. OriGene Technologies, Inc. Establishes High Throughput Monoclonal Antibody Production Outsourcing Center in China
6. China Biologic Products Receives High-Technology Enterprise Certification to Qualify for Preferential Income Tax Rate
7. China Pharma Holdings, Inc. Announces Clinical Trials Already Underway for Candesartan
8. China-Biotics, Inc. to Present at Roth Capital Partners 21st Annual OC Growth Stock Conference
9. Syngenta Enters Into Research Collaboration With Anhui Academy, China
10. China Sky One Medical, Inc. CFO to Present at Roth Conference
11. AMDL First to Implement US & China-Based, GAAP-Certified Accounting Technology to Capitalize on Lucrative China Healthcare Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , ... December 08, 2016 ... ... the commercial launch of flexible packaging for their exceptionally efficient human mesenchymal ... system extends RoosterBio’s portfolio of bioprocess media products engineered to radically streamline ...
(Date:12/8/2016)... , Dec. 8, 2016  HedgePath Pharmaceuticals, ... that discovers, develops and plans to commercialize innovative ... shares of common stock were approved for trading ... begin trading on the OTCQX, effective today, under ... for the OTCQX market, companies must meet high ...
(Date:12/7/2016)... ... December 07, 2016 , ... ACEA Biosciences, Inc. ... and expansion clinical trial for its lead drug candidate, AC0010, at the World ... trial was to determine the safety, antitumor activity, and recommended phase II dosage ...
(Date:12/7/2016)... , Dec. 7, 2016 /PRNewswire/ - Zenith Capital Corp. ("Zenith" or ... will be presented at the Company,s Annual and Special Meeting. ... Shareholders will take place on Thursday, December 15, 2016 at ... Hall (Room EC1040), 4825 Mount Royal Gate SW, ... A notice of meeting and management information circular, containing the ...
Breaking Biology Technology:
(Date:12/7/2016)... , Dec. 7, 2016   Avanade is ... Formula One teams in history, exploit biometric data in ... performance and maintain the competitive edge against their rivals ... Avanade has worked with Williams during ... of biometric data (heart rate, breathing rate, temperature and ...
(Date:12/5/2016)... , Dec. 5, 2016  The Office of ... published "Can CT Scans Enhance or Replace Medico ... potential of supporting or replacing forensic autopsies with ... scan. In response to recommendations made ... exploring using CT scans as a potential component ...
(Date:11/29/2016)... , Nov. 29, 2016 BioDirection, a privately ... products for the objective detection of concussion and other ... has successfully completed a meeting with the U.S. Food ... blood test Pre-Submission Package. During the meeting company representatives ... as a precursor to commencement of a planned pilot ...
Breaking Biology News(10 mins):